Alan W Dunton - Net Worth and Insider Trading

Alan W Dunton Net Worth

The estimated net worth of Alan W Dunton is at least $163,012 dollars as of 2024-04-29. Alan W Dunton is the Director of Palatin Technologies Inc and owns about 45,074 shares of Palatin Technologies Inc (PTN) stock worth over $82,035. Alan W Dunton is the Director of Cormedix Inc and owns about 15,250 shares of Cormedix Inc (CRMD) stock worth over $80,978. Alan W Dunton is also the Director of Catalyst Biosciences Inc and owns about 0 shares of Catalyst Biosciences Inc (CBIO) stock worth over $0. Details can be seen in Alan W Dunton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan W Dunton has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).

Transaction Summary of Alan W Dunton

To

Alan W Dunton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan W Dunton owns 6 companies in total, including Cormedix Inc (CRMD) , Palatin Technologies Inc (PTN) , and Oragenics Inc (OGEN) among others .

Click here to see the complete history of Alan W Dunton’s form 4 insider trades.

Insider Ownership Summary of Alan W Dunton

Ticker Comapny Transaction Date Type of Owner
CRMD Cormedix Inc 2023-12-15 director
PTN Palatin Technologies Inc 2023-12-04 director
OGEN Oragenics Inc 2015-12-15 director
CBIO Catalyst Biosciences Inc 2015-08-04 director
IMNPQ Immune Pharmaceuticals Inc 2013-08-12 director
MNOV MediciNova Inc 2006-05-11 director

Alan W Dunton Latest Holdings Summary

Alan W Dunton currently owns a total of 3 stocks. Among these stocks, Alan W Dunton owns 45,074 shares of Palatin Technologies Inc (PTN) as of December 4, 2023, with a value of $82,035 and a weighting of 50.32%. Alan W Dunton owns 15,250 shares of Cormedix Inc (CRMD) as of December 15, 2023, with a value of $80,978 and a weighting of 49.68%. Alan W Dunton also owns 0 shares of Catalyst Biosciences Inc (CBIO) as of August 2, 2010, with a value of $0 and a weighting of 0%.

Latest Holdings of Alan W Dunton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PTN Palatin Technologies Inc 2023-12-04 45,074 1.82 82,035
CRMD Cormedix Inc 2023-12-15 15,250 5.31 80,978
CBIO Catalyst Biosciences Inc 2010-08-02 0 7.67 0

Holding Weightings of Alan W Dunton


Alan W Dunton Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan W Dunton has made a total of 2 transactions in Palatin Technologies Inc (PTN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Palatin Technologies Inc is the sale of 200 shares on December 4, 2023, which brought Alan W Dunton around $496.

According to the SEC Form 4 filings, Alan W Dunton has made a total of 3 transactions in Cormedix Inc (CRMD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cormedix Inc is the acquisition of 6,000 shares on December 15, 2023, which cost Alan W Dunton around $20,280.

According to the SEC Form 4 filings, Alan W Dunton has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the sale of 57 shares on August 2, 2010, which brought Alan W Dunton around $133,800.

Insider Trading History of Alan W Dunton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan W Dunton Trading Performance

GuruFocus tracks the stock performance after each of Alan W Dunton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan W Dunton is 15.63%. GuruFocus also compares Alan W Dunton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan W Dunton within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alan W Dunton's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alan W Dunton

Average Return

44.78%

Average return per transaction

Outperforming Transactions

100%

8 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.65 15.63 52.52 44.78 16.06 3.6
Relative Return to S&P 500(%) 10.57 11.1 43.52 27.1 -1.05 -9.62

Alan W Dunton Ownership Network

Ownership Network List of Alan W Dunton

No Data

Ownership Network Relation of Alan W Dunton


Alan W Dunton Owned Company Details

What does Cormedix Inc do?

Who are the key executives at Cormedix Inc?

Alan W Dunton is the director of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Chief Financial Officer Matthew T David .

Cormedix Inc (CRMD) Insider Trades Summary

Over the past 18 months, Alan W Dunton made 2 insider transaction in Cormedix Inc (CRMD) with a net purchase of 9,000. Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 48,561 shares made by Joseph Todisco , a net purchase of 10,000 shares made by Paulo F Costa , and a net purchase of 10,000 shares made by Robert A Stewart .

In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 13,561 shares, with a net purchase of 13,561 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 84,561 shares were bought by its insiders, resulting in a net purchase of 84,561 shares.

Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cormedix Inc Insider Transactions

No Available Data

Alan W Dunton Mailing Address

Above is the net worth, insider trading, and ownership report for Alan W Dunton. You might contact Alan W Dunton via mailing address: Vicuron Pharmaceuticals Inc, 455 S Gulph Road Suite 305, King Of Prussia Pa 19406.

Discussions on Alan W Dunton

No discussions yet.